Aug 10 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2023 Jun 30, 2022 Jun 30, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.30 1.22 1.45
(+6.2 pct) (+8.8 pct) (+11.6 pct)
Operating 210 mln 191 mln 260 mln
(+10.4 pct) (+385.5 pct) (+23.2 pct)
Recurring 232 mln 253 mln 280 mln
(-8.1 pct) (+325.3 pct) (+20.4 pct)
Net
Net 285 mln 267 mln 280 mln
(+6.7 pct) (+360.0 pct) (-2.0 pct)
EPS 48.39 yen 45.39 yen 47.40 yen
EPS Diluted 45.39 yen
Ann Div 10.00 yen NIL 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 10.00 yen NIL 15.00 yen
NOTE - Human Metabolome Technologies, Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T